Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
Related Questions
How long would you anticoagulate a patient with recurrent VTE who has ongoing risk factors for intracranial bleeding?
What is your approach to management of unprovoked distal DVTs?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
What are your top takeaways from ISTH 2025?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
Would you recommend anticoagulation in subsequent pregnancies after symptomatic postpartum R ovarian vein thrombosis?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
For patients with a history of pregnancy loss, do you evaluate for PAI-1 polymorphisms as part of a thrombophilia workup?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
